I agree with all of that. We had agreement with ACEA, now part of SRNE.
Let's not forget that Sorrento has partnerships in Korea with Yuhan Corporation and in China with Lee’s Pharm as well as having a manufacturing arm through ACEA in China.
One element, among others, that we do not discuss much is the desire of Mexico to have it's own Vaccine development and manufacturing facility; a different color string down the road. Where do we stand with Dyadic? Question is, are plans in the making and is it a partnership, a division or could we buy something (it is Mexico soooo...).
We have a world map where we pin the location of our distributors and this weekend a pin for Sorrento headquarters in San Diego will get jammed in with running strings to every location where they have subsidiaries, partnerships, EUA and Divisions. One color for pre 2020 and another for the subsequent years. I have it in my head and it is interesting how many continents and countries it reaches into. Manufacturing in the USA and China with other sites that could be added in the coming years with purchases or partnerships will only broaden interest in the company in other countries. Nothing succeeds like success.
I came to believe Sorrento patterns after JNJ by being a holding company.
We have about 300MM shares OS, only 285 Institutions holding shares with 28.97% of the float while JNJ has 2.7B share OS, 4,199 institutions with 69.95% of the float. Get the PPS up and you can buy a lot of companies.
Said it before and I'll say it again, watching a great Novel being written each day and to have a wad of capital (risk) on the board as the wheel spins is pretty nerve splitting...but exciting.
News 
Market Data 
Discover 
